Home ›
Entities
› academia
› Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2
Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2
Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2
Summary
Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2 is a scholarly article[1].
Key Facts
Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2. Retrieved May 24, 2026, from https://4ort.xyz/entity/reinduction-chemoimmunotherapy-with-epratuzumab-in-relapsed-acute-lymphoblastic-leukemia-all-phase-ii-results-from-child
MLA“Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/reinduction-chemoimmunotherapy-with-epratuzumab-in-relapsed-acute-lymphoblastic-leukemia-all-phase-ii-results-from-child.
BibTeX@misc{4ortxyz_reinduction-chemoimmunotherapy-with-epratuzumab-in-relapsed-acute-lymphoblastic-leukemia-all-phase-ii-results-from-child_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2}}, year = {2026}, url = {https://4ort.xyz/entity/reinduction-chemoimmunotherapy-with-epratuzumab-in-relapsed-acute-lymphoblastic-leukemia-all-phase-ii-results-from-child}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2 — https://4ort.xyz/entity/reinduction-chemoimmunotherapy-with-epratuzumab-in-relapsed-acute-lymphoblastic-leukemia-all-phase-ii-results-from-child (retrieved 2026-05-24)
